• S.3289, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, pharmaceutical issues, and pet identification microchips. S.3288, Department of State, Foreign Operations and Related Programs Appropriations Act, FY2009, Women's Hospital issues. H.R.1105, Omnibus Appropriations Act, FY2009, Pharmaceutical issues, and pet identification microchips, and Women's Hospital issues. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, pharmaceutical issues, and pet identification microchips. Department of State, Foreign Operations and Related Programs Appropriations Act, FY2010, Women's Hospital issues.
• Pharmaceutical issues generally.
• H.R.1, American Recovery and Reinvestment Act of 2009, Medicare related provisions. Deferral of foreign source income related issues.

Duration: November 1, 2007 to February 28, 2009

General Issues: Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs, Pharmacy

Spending: about $140,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2007: House of Representatives, U.S. Senate, Y Y